Alliance Phase III Evaluation of Fixed Duration Zanubrutinib plus Sonrotoclax-Based Therapy Compared to Continuous Zanubrutinib in Previously Untreated Older Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Adult CIRB - Late Phase Emphasis Active Available to Open